Tvardi Therapeutics Inc.

TVRD | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.68

+$0.07 (+4.35%)

Sep 22, 2026, 1:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-18.21M	-70.87M	-118.51M	-20.54M	-88.44M	8.41M
Depreciation & Amortization	95K	192K	259K	85K	1.55M	1.01M
Stock-Based Compensation	1.4M	n/a	314K	246K	n/a	n/a
Other Working Capital	508K	5.36M	6.89M	2.67M	7.96M	-4.31M
Other Non-Cash Items	-7.29M	24.86M	16.01M	-321K	21.54M	-7.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	508K	-15.1M	10.17M	2.67M	5.26M	-7.37M
Operating Cash Flow	-23.5M	-60.92M	-92.08M	-17.87M	-60.09M	-5.49M
Capital Expenditures	n/a	-1.05M	-2.38M	-50K	-39K	-349K
Cash Acquisitions	n/a	n/a	n/a	n/a	70K	n/a
Purchase of Investments	-31.49M	-32.21M	-113.61M	-44M	-208.8M	-232.88M
Sales Maturities Of Investments	21.4M	82M	159.44M	22.05M	204.01M	212.96M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-10.08M	48.74M	43.46M	-22M	-4.75M	-20.28M
Debt Repayment	n/a	-3.6M	36.47M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	22.17M	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	22.7M	-3.6M	38.15M	4K	46.61M	39.14M
Net Cash Flow	-10.88M	-14.28M	-11.97M	-39.86M	-18.23M	13.38M
Free Cash Flow	-23.5M	-61.96M	-94.45M	-17.92M	-60.13M	-5.84M
Adj. Free Cash Flow	-24.9M	-61.96M	-94.77M	-18.16M	-60.13M	-5.84M
Maintenance CapEx	n/a	-1.05M	-2.38M	n/a	-39K	-349K
Growth CapEx	n/a	n/a	n/a	-50K	n/a	n/a
Owner Earnings	-23.5M	-61.96M	-94.45M	-17.87M	-60.13M	-5.84M